Skip to main content
Skip to content
Case File
efta-efta01733964DOJ Data Set 10Correspondence

EFTA Document EFTA01733964

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01733964
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
. 10(24/20168:08:55PM FROM: LABCORP LCLS BULK TO LABCORP Page 1 of 12 r TO: Sebastian Lig LatiCsarp SeemnimNundm 292-401- 3880-0 Nina hImmlWmibee 10416405675 AomumNurdso 31981645 . Rome 68 Psemtlasiblum Epstein AccovoAddren Sebastian Lighvani MD PMemlbruNsme Jeffrey PuiembtAlleNur lanbane npubame Age (YAM) 63/08/28 Defter/Bibb Sex 01/20/53 M Sudo& Yes lbseeaA&Imn 9 E 71ST ST NEW YORK NY 10021 Adobwmfledansem WPM: 812269 DassidnmeCoUftW 10/:8/16 17:56 I I DmeNeaW 10/16/16 I I DeeaSTimeRaipmed 10/24/16 20:06ET Physician Name LIGHVANI , S NM :407879885 AysicuoW LabCorp Raritan 69 First Avenue TeanekdalW CBC/Diff Ambiguous Default; Pneumococca: Ab (23 Serotype); Immmnoglobulins A/G/M On, Ser; Tetanus/Diphtheria Ab; Complement C4, Serum; TSR; Tryptase; Vitamin D, 25-Hydroxy; C/ Esterase Inhibitor, Punt; Histamine, Plasma; TSH Rfx on Abnormal to Pree T4; Antinuclear Antibodies Direct; Sedimentation Rate-Hestergron; Thyroid Antibodies; Vitamin 612; C-Reactive Protein, Want; Venipuncture TESTS CBC/Diff Ambiguous Default NBC BBC Macrocytes present. Marked anisocytosis. Hemoglobin Hematocrit MCV MCH MCHC RDW Platelets Neutrophils Lymph& Monocytes Eos Basos Neutrophils (Absolute) Lymphs (Absolute) Monocytes(Absolute) Boa (Absolute) Baso (Absolute) Immature Granulocytes Immature Grans (Abs) Hematology Comments: Verified by microscopic A hand-written panel/profile was received from your office. In accordance with the LabCorp Ambiguous Test Code Policy dated July 2003, we have assigned CBC with Differential/Platelet, Test Code 4005009 to this request. If this is not the testing you wished to receive on this specimen, please contact the LabCorp client Inquiry/ RESULT FLAG UNITS REFERENCE INTERVAL LAB 6.5 xl0E3/uL 3.4 - 10.8 01 4.96 xl0E6/uL 4.14 - 5.80 01 14.6 g/dL 12.6 17.7 01 41.3 % 37.5 51.0 01 83 fL 79 97 01 29.4 pg 26.6 33.0 01 35.4 g/dL 31.5 35.7 01 14.1 % 12.3 15.4 01 247 x10E3/uL 150 379 01 47 % 01 39 % 01 8 % 01 5 % 01 1 % 01 3.1 x10£3/uL 1.4 - 7.0 01 2.5 x10E3/uL 0.7 - 3.1 01 0.5 xl0E3/uL 0.1 - 0.9 01 0.4 x10E3/uL 0.0 - 0.4 01 0.0 x10E3/uL 0.0 - 0.2 01 0 % 01 0.0 x10£3/uL 0.0 - 0.1 01 Note: 01 examination. Epstein, Jeffrey 292-401-3880-0 Seq N 0393 10/24/16 20:06 ET FINAL REPORT This elccument contains mint and el:cadential health Informanon peotecled by state and federal law Dyes hat teceived this dcostrent in en. please call Page 1 of 4 O2004-16 labontosy Corporatien of America m Holdings AI I Km,hts Item bed DOC I Vex. 1.49 EFTA_R1_00010947 EFTA01733964 10/24/2016 8:06:55 PM FROM: LABCORP LCLS BULK LABCORP TO: Sebastian Lighvani M Page 2 of 12 r Labggarp PabeolNume Epstein, Jeffrey SronsoramS 292-401-3880-0 Account bombe: 31981645 ➢ara ID °so: Number 10416405675 Dafi acdTine Cobard 10/10/16 17:56 Date Recoiled 10/24/16 Sa 14 Are(YI740) 63/08/28 Due of Binb 01/20/53 LabCorp Raritan 69 Brat Avenue Raritan. 08869-1 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAS Technical Services Department to clarify the test order. appreciate your business. Pneumococcal Ab (23 Serotype) Pneumo Ab Type 1* Pneumo Ab Pneumo Ab Type Type 3* 4* Pneumo Ab Type 8e Pneumo Ab Type 9 (98)* Pneumo Ab Type 12 (12F)* Pneumo Ab Type 14* Pneumo Ab Type 17 (17F)* Pneumo Ab Type 19 (19F)* Pneumo Ab Type 2* Pneumo Ab Type 20* Pneumo Ab Type 22 (22F)* Pneumo Ab Type 23 (23P)* Pneumo Ab Type 26 (6B)* Pneumo Ab Type 34 (10A)* Pneumo Ab Type 43 (12A)* Pneumo Ab Type 5* Pneumo Ab Type 51 (7F)* Pneumo Ab Type 54 (258)* Pneumo Ab Type 56 (18C)* Pneumo Ab Type 57 (19A)* Pneumo Ab Type 68 (9V)* Pneumo Ab Type 70 (33F)* 0.8 Low 0.6 Low 0.8 Low 0.5 Low Low cit, Low Low <0.1 Low 0.2 Low 0.9 Low C0 7) 0.7 Low C61r Low Low ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL U /mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/mL ug/ML ug/mL ug/mL ug/mL ug/mL *This test was developed and performance characteristics determined by Viracor-I8T Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. we immunoglobuline A/O/N, Immunoglobulin G, Qn, Immunoglobulin A, Qn, Immunoglobulin 8, Qn, Qn, Ser Serum Serum Serum Tetanus/Diphtheria Ab Tetanus Antitoxoid IgG Ab 994.7 216t/ 41LX' mg/dL mg/dL mg/dL >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >2.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 >1.3 700 - 1600 61 - 437 20 - 172 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 02 01 01 01 2.0: v IU/mL <0.10 03 Interpretation: Non-Protective <0.10 Protective >=0.10 Results for this test are for research purposes only by the assay's manufacturer. The performance characteristics of this product have not been established. Results should not be used as a diagnostic procedure without confirmation of the Epstein, Jeffrey 292-401-3880-0 scqsa393 10/24/16 20:06 ET FINAL REPORT This document contains pins and confidential health naformatton 'erected try state and retinal law. If you have received this doctunent 1n ma. please c Page 2 of 4 O200916 Laboratory Corpantica of America W Holdinpn All Rie,hts Reserved DOC1 Vet: 1A9 EFTA_R1_00010948 EFTA01733965 10/24/2016 8:06:55 PM FROM: LABCORP LCLS BULK TO: LABCORP TO: Sebastian Ligh,P. Pap 3 of 12 r Epstein, Jeffrey occeout Mmbet 31981645 TESTS LabCorp Raritan 69 First Avenue Raritan, NJ 08869-1800 Phone PreenNum Spe 292-401-3880-0 Rem D Control tOrn:Wt Dew sodOme Collected Dee Mowed Scz Ate(aM/D) Doe of Birtb 10416405675 10/18/16 17:56 10/24/16 63/08/28 _ 01/20/53 RESULT FLAG UNITS REFERENCE INTERVAL LLB diagnosis by another medically established diagnostic product or procedury Diphtheria Antitoxoid Ab 0.15 o Complement C4, Serum ESN Tryptase For research use only. 26 1.740 L/e/ 5.0  IU/mL <0.10 Interpretation: Non-Protective <0.10 Protective >=0.10 mg/dL uI13/mL ug/L Vitamin D, 25-Hydroxy 31.07 ng/mL Vitamin D deficiency has been defined by the Institute of Medicine and an Endocrine Society practice guideline as a level of serum 25-0H vitamin D less than 20 ng/mL (1,2). The Endocrine Society went on to further define vitamin D insufficiency as a level between 21 and 29 ng/r1 (2). 1. ION (Institute of Medicine). 2010. Dietary reference intakes for calcium and D. Washington DC: The National Academies Press. 2. Holick MF, Hinkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011 Jul; 96(7):1911-30. Cl Esterase Inhibitor, rune Cl Est.Inhib.Funct. :09 Histamine, Plasma Results for this test are f manufacturer. The performance not been established. Results procedure without confirmation established diagnostic product %mean normal Abnormal Equivocal Normal :4 0.450 2.2 30.0 03 - 44 01 - 4.500 0: - 13.2 03 - 100.0 0: <41 41 - 67 >67 03 High ,_V <1.00 03 earch p oses only by the assay's characteristics of this product have should not be used as a diagnostic of the diagnosis by another medically or procedure. TSN Rfx on Abnormal to Free T4 TSH 1.700 V . u:U/ML 0.450 - 4.500 01 Epstein, Jeffrey 10/24/16 20:06 ET FINAL REPORT This documentcontains pints and confidential health thfonnation otorled by dm and federal law. If you have received dal dec.unent w arcs. please cal 292-401-3880-0 f swim-3 Page 3 of 4 02004-16 Lab:eatery Corponflon of America E lictehngs AU Rights Reserved DOC1 Vc: 1.49 EFTA_R1_00010949 EFTA01733966 . 10/24/2016 8:06:55 PM FROM: LABCORP LCLS BULK LASCORP TO: Sebastian Lighvan Page 4 of 12 r Lallov Nths Name Epstein, Jeffrey Smonsc :tea 292-401-3880-0 Account Swam 31981645 Padeu M crape Numbet 10416405675 Demand rime Named 10/18/16 17:56 Due Repotted 10/24/16 Sex M AteNaMM 63/08/28 Dm of Bum 01/20/53 LabCorp Raritan 69 First Avenue liarLan NJ 08869-18tH! Phone TESTS RESULT UNITS REFERENCE INTERVAL LAB Antinuclear Antibodies Direct ANA Direct Sedimentation Rate -Westergren Thyroid Antibodies Thyroid Peroxidase (TP0) Thyroglobulin Antibody Negative Negative 20 mm/hr 0 Ab 8 IU/mL 0 <1.0  IU/mL 0.0 Thyroglobulin Antibody measured by Beckman Vitamin B12 C-Reactive Protein, Coulter Methodology 755 pg/mL 211 Quant 1.7 v" mg/L 0.0 01 RN LabCorp Raritan 69 First Avenue, Raritan, NJ 08869-1800 02 NEWXW Viracor 1ST Laboratories Inc 1001 NW Technology Drive, Lees Summit, HO 03 BN LabCorp Burlington For inquiries, the physician may contact Branche 1447 York Court, Burlington, NC 272111 Labs Dir: Aracell B Reyes, MD Dir: Michelle Altrich, PhD 64086-5603 Dir: William F Hancock, MD 01 - 30 01 - 34 - 0.9 - 946 - 4.9 01 01 01 01 292-401-3880-0 Scq N 0393 Epstein, Jeffrey 10/24/16 20:06 ET FINAL REPORT Ibis document cameos pdva lc and confidential health inform/ sled by slam and fetal law. If you ban received des doormenlin error. plea= call Page 4 of 4 02004-.16 Laboratory Corporation of America 0 'folding, All Rights Sesame DOCI Vet: 1.49 EFTA_R1_00010950 EFTA01733967

Related Documents (6)

Court UnsealedSep 9, 2019

Epstein Depositions

10. 11. 12. l3. 14. 16. 17. l8. 19. Jeffrey Epstein v. Bradley J. Edwards, et Case No.: 50 2009 CA Attachments to Statement of Undisputed Facts Deposition of Jeffrey Epstein taken March 17, 2010 Deposition of Jane Doe taken March 11, 2010 (Pages 379, 380, 527, 564?67, 568) Deposition of LM. taken September 24, 2009 (Pages 73, 74, 164, 141, 605, 416) Deposition ofE.W. taken May 6, 2010 (1 15, 1.16, 255, 205, 215?216) Deposition of Jane Doe #4 (32-34, 136) Deposition of Jeffrey Eps

839p
DOJ Data Set 9OtherUnknown

UNITED STATES DISTRICT COURT

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK x UNITED STATES OF AMERICA S 120 Cr. 330 (AJN) GHISLAINE MAXWELL, Defendant. x THE GOVERNMENT'S OMNIBUS MEMORANDUM IN OPPOSITION TO THE DEFENDANT'S PRE-TRIAL MOTIONS AUDREY STRAUSS United States Attorney Southern District of New York Attorney for the United States of America Assistant United States Attorneys - Of Counsel - EFTA00039421 TABLE OF CONTENTS PRELIMINARY STATEMENT 1 BACKGROUND 2 ARGUMENT 3 I. Jeffrey Epstein's Non-Prosecution Agreement Is Irrelevant to This Case 3 A. The NPA Does Not Bind the Southern District of New York 4 1. The Text of the Agreement Does Not Contain a Promise to Bind Other Districts 5 2. The Defendant Has Offered No Evidence That the NPA Binds Other Districts 9 B. The NPA Does Not Immunize Maxwell from Prosecution 15 1. The NPA Is Limited to Particular Crimes Between 2001 and 2007 15 2. The NPA Does Not Confer Enforceable Rights on Maxwell 17 C. The Defendant

239p
DOJ Data Set 10OtherUnknown

EFTA01682184

186p
DOJ Data Set 11OtherUnknown

EFTA02335898

51p
DOJ Data Set 10CorrespondenceUnknown

EFTA Document EFTA01867203

0p
DOJ Data Set 10OtherUnknown

EFTA01733964

4p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.